Cargando…
Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe
WHO launched the Good Governance for Medicines (GGM) programme in 2004 with the aim of fighting the problem of corruption in the pharmaceutical sector. Zimbabwe adopted the GGM programme in 2015 and developed its own implementation framework (GGM-IF) in 2017 based on the WHO global guidelines and re...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756290/ https://www.ncbi.nlm.nih.gov/pubmed/35022182 http://dx.doi.org/10.1136/bmjgh-2021-007548 |
_version_ | 1784632539303903232 |
---|---|
author | Maponga, Charles Chiedza Chikwinya, Takudzwa Hove, Ropa Madzikwa, Newman Mazambara, Fine Midzi, Stanley M Mudzimu, Forward Ndlovu, Misheck Ngirande, William Vengesayi, Ndanatseyi Mhazo, Alison T |
author_facet | Maponga, Charles Chiedza Chikwinya, Takudzwa Hove, Ropa Madzikwa, Newman Mazambara, Fine Midzi, Stanley M Mudzimu, Forward Ndlovu, Misheck Ngirande, William Vengesayi, Ndanatseyi Mhazo, Alison T |
author_sort | Maponga, Charles Chiedza |
collection | PubMed |
description | WHO launched the Good Governance for Medicines (GGM) programme in 2004 with the aim of fighting the problem of corruption in the pharmaceutical sector. Zimbabwe adopted the GGM programme in 2015 and developed its own implementation framework (GGM-IF) in 2017 based on the WHO global guidelines and recommendations. Zimbabwe’s GGM-IF emerged from; (1) home-based expertise, (2) extensive local consultations and (3) effective incorporation into existing institutions. The GGM-IF committed to implementing a focused programme over a 5-year period from 2017 to 2022 with the expressed goal of improving transparency and accountability in the pharmaceutical sector as a key enabler to improve access to medicines. Midway through its projected lifespan, some notable achievements materialised attributed to key success drivers, including mutual collaboration with the Ministry of Health and Child Care’s existing Global Fund supported Quality Assurance Programme. Key challenges faced include limited funding for the programme, a shifting policy environment driven by a political transition and reorientation of priorities in the wake of the COVID-19 pandemic. This manuscript articulates 3-year operationalisation of Zimbabwe’s GGM-IF highlighting the success drivers, implementation challenges and lessons learnt. |
format | Online Article Text |
id | pubmed-8756290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87562902022-01-26 Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe Maponga, Charles Chiedza Chikwinya, Takudzwa Hove, Ropa Madzikwa, Newman Mazambara, Fine Midzi, Stanley M Mudzimu, Forward Ndlovu, Misheck Ngirande, William Vengesayi, Ndanatseyi Mhazo, Alison T BMJ Glob Health Practice WHO launched the Good Governance for Medicines (GGM) programme in 2004 with the aim of fighting the problem of corruption in the pharmaceutical sector. Zimbabwe adopted the GGM programme in 2015 and developed its own implementation framework (GGM-IF) in 2017 based on the WHO global guidelines and recommendations. Zimbabwe’s GGM-IF emerged from; (1) home-based expertise, (2) extensive local consultations and (3) effective incorporation into existing institutions. The GGM-IF committed to implementing a focused programme over a 5-year period from 2017 to 2022 with the expressed goal of improving transparency and accountability in the pharmaceutical sector as a key enabler to improve access to medicines. Midway through its projected lifespan, some notable achievements materialised attributed to key success drivers, including mutual collaboration with the Ministry of Health and Child Care’s existing Global Fund supported Quality Assurance Programme. Key challenges faced include limited funding for the programme, a shifting policy environment driven by a political transition and reorientation of priorities in the wake of the COVID-19 pandemic. This manuscript articulates 3-year operationalisation of Zimbabwe’s GGM-IF highlighting the success drivers, implementation challenges and lessons learnt. BMJ Publishing Group 2022-01-12 /pmc/articles/PMC8756290/ /pubmed/35022182 http://dx.doi.org/10.1136/bmjgh-2021-007548 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Practice Maponga, Charles Chiedza Chikwinya, Takudzwa Hove, Ropa Madzikwa, Newman Mazambara, Fine Midzi, Stanley M Mudzimu, Forward Ndlovu, Misheck Ngirande, William Vengesayi, Ndanatseyi Mhazo, Alison T Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe |
title | Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe |
title_full | Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe |
title_fullStr | Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe |
title_full_unstemmed | Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe |
title_short | Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe |
title_sort | lessons learnt from implementing the good governance for medicines programme in zimbabwe |
topic | Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756290/ https://www.ncbi.nlm.nih.gov/pubmed/35022182 http://dx.doi.org/10.1136/bmjgh-2021-007548 |
work_keys_str_mv | AT mapongacharleschiedza lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe AT chikwinyatakudzwa lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe AT hoveropa lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe AT madzikwanewman lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe AT mazambarafine lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe AT midzistanleym lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe AT mudzimuforward lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe AT ndlovumisheck lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe AT ngirandewilliam lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe AT vengesayindanatseyi lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe AT mhazoalisont lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe |